NCT05301803View on ClinicalTrials.gov

An Evaluation of the Safety and Performance of the CathVision ECGenius® System.

CompletedOBSERVATIONAL

Enrollment

27

Participants

Timeline

Start Date

March 29, 2022

Primary Completion Date

April 30, 2022

Study Completion Date

December 31, 2023

Conditions

Cardiac Arrhythmia

Interventions

DEVICE

Electrophysiology procedure

Electrophysiology testing and cardiac ablation of arrhythmia

Trial Locations (1)

05401

The University of vermont, Burlington

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors

collaborator

Medicept Inc.

INDUSTRY

lead

CathVision ApS

INDUSTRY

NCT05301803 - An Evaluation of the Safety and Performance of the CathVision ECGenius® System. | Biotech Hunter | Biotech Hunter